Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | December 06, 2013 | February 04, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 06, 2013 · Filed February 04, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 79,747 |
Ending reported balance
After 2012-12-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-12-06 · Gift · Disposed 7,700 · Balance 83,447 Row 2 · 2012-12-07 · Gift · Disposed 3,700 · Balance 79,747 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2010 Filed Feb 24, 2010 01:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003577 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,600 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003577 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,600 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 133,838 | $0.00 Strike: $55.92 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · derivative · entry 7 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,838 Underlying: Common Shares · 133,838 shares Expires 2018-05-29 F7 · security: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 326,200 shares of Advanced Medical Optics, Inc. common stock for $22.94 per share. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 75,904 | $0.00 Strike: $93.11 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · derivative · entry 6 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,904 Underlying: Common Shares · 75,904 shares Expires 2015-05-26 F6 · security: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 185,000 shares of Advanced Medical Optics, Inc. common stock for $38.20 per share. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 82,058 | $0.00 Strike: $82.19 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · derivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,058 Underlying: Common Shares · 82,058 shares Expires 2014-05-20 F5 · security: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 200,000 shares of Advanced Medical Optics, Inc. common stock for $33.72 per share. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 49,235 | $0.00 Strike: $33.76 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · derivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,235 Underlying: Common Shares · 49,235 shares Expires 2013-04-29 F4 · security: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 120,000 shares of Advanced Medical Optics, Inc. common stock for $13.85 per share. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 98,470 | $0.00 Strike: $21.92 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · derivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,470 Underlying: Common Shares · 98,470 shares Expires 2012-07-29 F3 · security: Fully vested employee stock option received pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. (the "Merger Agreement") in exchange for an employee stock option to acquire 240,000 shares of Advanced Medical Optics, Inc. common stock for $8.99 per share. Read SEC document |
| February 26, 2008 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F2 · shares: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year and include the right to have stock withheld for tax purposes. Read SEC document |
| February 26, 2008 Filed Mar 3, 2009 02:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-013603 · a4.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program subject to an 18-month cliff vesting period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.